Landiolol for Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery

NCT05084118 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

164

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Postoperative Complications

Interventions

DRUG: Landiolol HCl
DRUG: Placebo

Sponsor

Medical University of Vienna